Synergy Pharma Faces Pushback Over Ch. 11 Plan Releases
Synergy Pharmaceuticals Inc. is facing challenges to its Chapter 11 plan disclosures from the U.S. Securities and Exchange Commission and the plaintiffs in a shareholder class action who say the plan...To view the full article, register now.
Already a subscriber? Click here to view full article